Department of Psychiatry, Radboud University Medical Centre, 6525, EX, Nijmegen, The Netherlands.
Department of Psychiatry, Radboud University Medical Centre for Mindfulness, Reinier Postlaan, Postbus 9101, 6500, HB, Nijmegen, The Netherlands.
J Clin Psychol Med Settings. 2021 Sep;28(3):419-426. doi: 10.1007/s10880-021-09776-2. Epub 2021 Jun 17.
Fear of Cancer Recurrence (FCR) is a concern among cancer patients. Recent insights suggest that FCR should be viewed as a distinct syndrome. However, few studies have explored its overlap with psychiatric morbidity. We examined this overlap in a sample of distressed cancer patients. Self-referred patients (n = 245) were assessed with the Structured Clinical Interview for DSM-IV-TR Axis-I disorders and the Fear of Cancer Recurrence Inventory-Short Form. Proportions of patients with and without a psychiatric disorder meeting validated cut-offs for screening and clinically relevant FCR were compared. The prevalence of psychiatric disorders was 36%. Clinically relevant FCR was found in 198 patients (81%). Patients with a current psychiatric disorder reported clinically relevant FCR more frequently (89%) compared to those with no disorder (77%). Of patients reporting clinically relevant FCR, the majority (61%) did not additionally meet the criteria for a psychiatric disorder. These findings suggest that there should be particular attention for patients with elevated levels of FCR, warranting FCR-specific treatment.Trial registry number Clinicaltrials.gov NCT02138513.
癌症复发恐惧 (Fear of Cancer Recurrence, FCR) 是癌症患者关注的问题。最近的研究结果表明,FCR 应该被视为一种独特的综合征。然而,很少有研究探讨其与精神疾病发病率的重叠。我们在一组焦虑的癌症患者中研究了这种重叠。自我转诊的患者(n=245)接受了 DSM-IV-TR 轴 I 障碍的结构化临床访谈和癌症复发恐惧量表-短式的评估。比较了符合筛选和临床相关 FCR 验证标准的有和没有精神障碍的患者的比例。精神障碍的患病率为 36%。在 198 名患者中发现了临床相关的 FCR(81%)。与没有障碍的患者(77%)相比,目前患有精神障碍的患者更频繁地报告临床相关的 FCR(89%)。在报告临床相关 FCR 的患者中,大多数(61%)并未另外符合精神障碍的标准。这些发现表明,对于 FCR 水平升高的患者应特别关注,需要进行 FCR 特异性治疗。试验注册号:Clinicaltrials.gov NCT02138513。